1.034EUR+3.92%Mkt Cap: 91.84M EURP/E: —Last update: 2026-05-29
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies,…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap91.84M EUR
Enterprise Value74.41M EUR
Revenue (TTM)5.42M EUR
Gross Profit3.04M EUR
Net Income (TTM)-17.90M EUR
Revenue/Share0.0640 EUR
Last Price1.034 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees139
CountryFI
SectorHealthcare
IndustryBiotechnology
ISINFI4000330972
Valuation
P/E (Trailing)—
P/E (Forward)-8.27
PEG—
EV/EBITDA-4.45
EV/Revenue13.73
P/S16.34
P/B2.23
EPS (TTM)-0.19
EPS (Forward)-0.13
52W Range
0.377065% of range1.382
52W High1.382 EUR
52W Low0.3770 EUR
Profitability
Gross Margin85.82%
Oper. Margin-262.56%
EBITDA Margin0.00%
Profit Margin-504.74%
ROE-41.84%
ROA-33.16%
Growth
Revenue Growth45.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.66M EUR
CapEx (TTM)1.14M EUR
FCF Margin-205.15%
FCF Yield-12.11%
Net Debt-14.17M EUR
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.15
Current Ratio4.01
Quick Ratio3.79
Book Value/Sh0.4640 EUR
Cash/Share0.2400 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)2.125 EUR
Target Range2.000 EUR – 2.250 EUR
# Analysts2
Ownership
Shares Out.85.67M
Float24.62M
Insiders23.30%
Institutions40.38%
Technical
SMA 500.6363 (+62.5%)
SMA 2000.8772 (+17.9%)
Beta0.56
S&P 52W Chg27.94%
Avg Vol (30d)283.55K
Avg Vol (10d)286.32K
Technical Indicators
RSI (14)69.7
MACD0.1010
MACD Signal0.0822
MACD Hist.+0.0188
BB Upper1.141 EUR
BB Middle0.7609 EUR
BB Lower0.3804 EUR
BB Width100.01%
ATR (14)0.0880 EUR
Vol Ratio (20d)0.85x